Jazz Pharmaceuticals (JAZZ) Competitors $129.59 +0.19 (+0.15%) Closing price 09/24/2025 04:00 PM EasternExtended Trading$128.49 -1.10 (-0.85%) As of 09/24/2025 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock JAZZ vs. AXSM, RPRX, CORT, PRGO, SUPN, PCRX, NKTR, OMER, ASMB, and CPIXShould you be buying Jazz Pharmaceuticals stock or one of its competitors? The main competitors of Jazz Pharmaceuticals include Axsome Therapeutics (AXSM), Royalty Pharma (RPRX), Corcept Therapeutics (CORT), Perrigo (PRGO), Supernus Pharmaceuticals (SUPN), Pacira BioSciences (PCRX), Nektar Therapeutics (NKTR), Omeros (OMER), Assembly Biosciences (ASMB), and Cumberland Pharmaceuticals (CPIX). These companies are all part of the "medical" sector. Jazz Pharmaceuticals vs. Its Competitors Axsome Therapeutics Royalty Pharma Corcept Therapeutics Perrigo Supernus Pharmaceuticals Pacira BioSciences Nektar Therapeutics Omeros Assembly Biosciences Cumberland Pharmaceuticals Axsome Therapeutics (NASDAQ:AXSM) and Jazz Pharmaceuticals (NASDAQ:JAZZ) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation and media sentiment. Does the media refer more to AXSM or JAZZ? In the previous week, Axsome Therapeutics and Axsome Therapeutics both had 16 articles in the media. Axsome Therapeutics' average media sentiment score of 0.90 beat Jazz Pharmaceuticals' score of 0.79 indicating that Axsome Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Axsome Therapeutics 9 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Jazz Pharmaceuticals 8 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive Do analysts recommend AXSM or JAZZ? Axsome Therapeutics presently has a consensus price target of $177.86, suggesting a potential upside of 49.75%. Jazz Pharmaceuticals has a consensus price target of $178.93, suggesting a potential upside of 38.08%. Given Axsome Therapeutics' stronger consensus rating and higher probable upside, research analysts clearly believe Axsome Therapeutics is more favorable than Jazz Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Axsome Therapeutics 0 Sell rating(s) 0 Hold rating(s) 13 Buy rating(s) 2 Strong Buy rating(s) 3.13Jazz Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.88 Do institutionals and insiders have more ownership in AXSM or JAZZ? 81.5% of Axsome Therapeutics shares are owned by institutional investors. Comparatively, 89.1% of Jazz Pharmaceuticals shares are owned by institutional investors. 22.3% of Axsome Therapeutics shares are owned by company insiders. Comparatively, 4.3% of Jazz Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more risk and volatility, AXSM or JAZZ? Axsome Therapeutics has a beta of 0.54, indicating that its stock price is 46% less volatile than the S&P 500. Comparatively, Jazz Pharmaceuticals has a beta of 0.24, indicating that its stock price is 76% less volatile than the S&P 500. Is AXSM or JAZZ more profitable? Jazz Pharmaceuticals has a net margin of -9.91% compared to Axsome Therapeutics' net margin of -49.88%. Jazz Pharmaceuticals' return on equity of 5.02% beat Axsome Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Axsome Therapeutics-49.88% -283.22% -33.06% Jazz Pharmaceuticals -9.91%5.02%1.73% Which has stronger valuation and earnings, AXSM or JAZZ? Jazz Pharmaceuticals has higher revenue and earnings than Axsome Therapeutics. Axsome Therapeutics is trading at a lower price-to-earnings ratio than Jazz Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAxsome Therapeutics$495.03M11.97-$287.22M-$5.07-23.43Jazz Pharmaceuticals$4.07B1.93$560.12M-$6.73-19.26 SummaryAxsome Therapeutics and Jazz Pharmaceuticals tied by winning 8 of the 16 factors compared between the two stocks. Get Jazz Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JAZZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JAZZ vs. The Competition Export to ExcelMetricJazz PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.85B$3.15B$5.77B$10.42BDividend YieldN/A2.36%5.68%4.62%P/E Ratio-19.2620.7676.2826.42Price / Sales1.93444.32553.28128.19Price / Cash4.2645.9137.5661.52Price / Book1.919.8313.186.39Net Income$560.12M-$52.73M$3.29B$271.13M7 Day Performance-1.22%1.84%0.84%0.93%1 Month Performance4.01%7.48%5.03%7.52%1 Year Performance20.15%19.92%71.27%30.06% Jazz Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JAZZJazz Pharmaceuticals4.4281 of 5 stars$129.59+0.1%$178.93+38.1%+18.8%$7.85B$4.07B-19.262,800Positive NewsAnalyst ForecastAXSMAxsome Therapeutics4.8921 of 5 stars$116.78-1.4%$177.86+52.3%+30.1%$5.83B$385.69M-23.03380Insider TradeRPRXRoyalty Pharma4.8577 of 5 stars$35.15-3.3%$48.00+36.6%+29.1%$20.50B$2.26B20.3280CORTCorcept Therapeutics4.7608 of 5 stars$69.53-4.6%$135.25+94.5%+90.5%$7.33B$716.08M61.53300Positive NewsPRGOPerrigo4.784 of 5 stars$21.76-2.3%$33.00+51.7%-19.3%$2.99B$4.37B-37.518,379SUPNSupernus Pharmaceuticals2.8959 of 5 stars$43.99-3.2%$43.00-2.3%+54.1%$2.47B$665.13M38.25580Insider TradePCRXPacira BioSciences3.7221 of 5 stars$26.86-1.0%$30.83+14.8%+82.7%$1.21B$700.97M-9.66720Positive NewsNKTRNektar Therapeutics4.0571 of 5 stars$49.01+0.7%$88.33+80.2%+232.4%$932.17M$98.43M-5.57220Analyst ForecastOMEROmeros3.9054 of 5 stars$4.09-1.4%$18.00+340.1%+7.7%$278.37MN/A-1.94210ASMBAssembly Biosciences3.7002 of 5 stars$21.19-3.0%$41.33+95.1%+69.4%$162.57M$33.25M-3.80100News CoverageAnalyst ForecastGap UpCPIXCumberland Pharmaceuticals0.3446 of 5 stars$3.38-1.7%N/A+153.3%$50.57M$42.07M-15.3680 Related Companies and Tools Related Companies AXSM Alternatives RPRX Alternatives CORT Alternatives PRGO Alternatives SUPN Alternatives PCRX Alternatives NKTR Alternatives OMER Alternatives ASMB Alternatives CPIX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:JAZZ) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jazz Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Jazz Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JAZZ Stock Alerts